| |
|
|
Kyverna Therapeutics Inc (NASDAQ: KYTX) |
|
|
|
|
Kyverna Therapeutics Inc 's Operating Profit Margin, Return on Sales by quarter
Trends, Rankings, Statistics
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Profit Margin, Return on Sales ▼
|
Operating Profit Margin, Return on Sales ▼
|
| KYTX Operating Profit Margin, Return on Sales |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q1 |
| Y / Y Revenue Change |
- |
- |
- |
- |
- |
| Seq. Revenue Change |
- |
- |
- |
- |
- |
| Revenue In Millions |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Profit Margin, Return on Sales |
- |
- |
- |
- |
- |
| Operating Profit Margin, Return on Sales Total
Ranking |
# |
# |
# |
# |
# |
| Operating Income In Millions |
$-47.41 |
$-41.04 |
$-38.77 |
$-33.44 |
$-29.36 |
| Y / Y Operating Income Change |
- |
- |
- |
- |
- |
| Seq. Operating Income Change |
- |
- |
- |
- |
- |
| KYTX's Operating Profit Margin, Return on Sales first quarter 2025 Company Ranking |
| Within: |
No. |
| Biotechnology & Pharmaceuticals Industry |
# |
| Healthcare Sector |
# |
| Overall |
# 0 |
| Operating Profit Margin, Return on Sales Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| Companies with similar Operating Profit Margin, Return on Sales in the quarter ending Mar 31 2025, within Biotechnology & Pharmaceuticals Industry | Operating Profit Margin, Return on Sales | Mar 31 2025 MRQ Operating Income | Mar 31 2025 MRQ Revenue |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
